Stock of the Day
August 28, 2023
Insulet (PODD)
$312.55
-$4.61 (-1.5%)
Market Cap:
$22.01B
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours.
The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
← Previous Stock of the Day
Next Stock of the Day →
Recent News
3 Medical Technology Stocks Outperforming in 2025
(marketbeat.com)
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
(msn.com)
TD Cowen Raises Insulet (PODD) Price Target, Maintains Buy Rating
(insidermonkey.com)
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)
(msn.com)
1 Surging Stock with Exciting Potential and 2 to Question
(finance.yahoo.com)
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
(benzinga.com)
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Rating
(insidermonkey.com)
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Recommendation
(msn.com)
Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy
(finance.yahoo.com)
Goldman Sachs Initiates Coverage on Insulet (PODD) with Buy Rating | PODD Stock News
(gurufocus.com)